Hospital admissions during Covid-19 lock-down in Germany: Differences in discretionary and unavoidable cardiovascular

Elisabeth Stöhr1, Adem Aksoy1, Meghan Campbell1,2

  • 1Department of Cardiology, Heart Center, University of Bonn, Bonn, Germany.

Plos One
|November 20, 2020
PubMed

Insights

During Covid-19 lockdowns, emergency cardiovascular admissions in western Germany decreased by 20%. This decline primarily affected non-urgent cases like heart failure and dizziness, while critical events such as STEMI and stroke remained stable.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Reports indicated a decline in cardiovascular events and catheter laboratory activations in the US and Italy during early COVID-19.
  • This study focuses on emergency cardiovascular event services in a specific region of western Germany during a government-imposed lockdown.

Purpose of the Study:

  • To analyze the impact of the COVID-19 pandemic lockdown on emergency cardiovascular event admissions in western Germany.
  • To compare admission rates during the lockdown period with the same timeframe in the previous year.

Main Methods:

  • Examined 5799 consecutive patients treated for cardiovascular events between January 1 and April 30, 2020.
  • Compared data with the corresponding period in 2019, utilizing emergency physician records from nine locations.
  • Calculated the overall decline in cardiovascular admissions.

Main Results:

  • A 20% overall decline in cardiovascular admissions was observed during the lockdown.
  • Greatest reductions were seen in admissions for dizziness/syncope (-53%), heart failure (-38%), COPD exacerbations (-28%), and unstable angina (-23%).
  • Admissions for ST-elevation myocardial infarction (STEMI), cardiopulmonary resuscitation (CPR), and stroke remained unchanged. Older adults (≥60 years) and urban residents showed greater declines.

Conclusions:

  • The COVID-19 lockdown in western Germany led to a significant decrease in hospitalizations for cardiovascular events.
  • The reduction was primarily driven by "discretionary" cardiovascular conditions, not by unavoidable emergencies like STEMI or stroke.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
193
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
213
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
141
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.8K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
140
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.6K